Truist Securities Maintains Buy on Axogen, Raises Price Target to $60
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.